|
gptkb:Tafluprost
|
use only if potential benefit justifies potential risk
|
|
gptkb:fingolimod
|
teratogenic
|
|
gptkb:leflunomide
|
teratogenic
|
|
gptkb:Afatinib
|
may cause fetal harm
|
|
gptkb:Meloxicam
|
may cause harm in late pregnancy
|
|
gptkb:ibrutinib
|
may cause fetal harm
|
|
gptkb:griseofulvin
|
may cause fetal harm
|
|
gptkb:Niraparib
|
may cause fetal harm
|
|
gptkb:Imbruvica
|
may cause fetal harm
|
|
gptkb:azacitidine
|
may cause fetal harm
|
|
gptkb:brentuximab_vedotin
|
may cause fetal harm
|
|
gptkb:Gilenya
|
may cause fetal harm
|
|
gptkb:Hydroxyzine
|
may cause fetal harm
|
|
gptkb:CellCept
|
may cause birth defects
|
|
gptkb:olmesartan_medoxomil
|
may cause fetal toxicity
|
|
gptkb:Palbociclib
|
may cause fetal harm
|
|
gptkb:cariprazine
|
may cause extrapyramidal and/or withdrawal symptoms in neonates
|
|
gptkb:Sustiva
|
may cause birth defects
|
|
gptkb:Entresto
|
may cause fetal harm
|
|
gptkb:finasteride
|
may cause birth defects in male fetus
|